Arkolith/Insider Trading/NKTR/Form 4

Robin Howard W

President & CEO, DirectorNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Nov 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$120K
Net Open-Market Flow
-$120K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Sell(S)2K$54.28$120K54K
Nov 21, 2025Grant(A)7K—$056K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2025Grant(A)12K—$012K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-297850) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML